Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA. (Q44833577)

6 December 2017

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA. (English)

1 reference

6 December 2017

5

1 reference

6 December 2017

11

Britta Wahren

1 reference

6 December 2017

Anne Kjerrström Zuber

1

1 reference

6 December 2017

Andreas Bråve

2

1 reference

6 December 2017

Gunnel Engström

3

1 reference

6 December 2017

Bartek Zuber

4

1 reference

6 December 2017

Malin Fredriksson

6

1 reference

6 December 2017

Reinhold Benthin

7

1 reference

6 December 2017

Maria G Isaguliants

8

1 reference

6 December 2017

Eric Sandström

9

1 reference

6 December 2017

Jorma Hinkula

10

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

22

1 reference

6 December 2017

13-14

1 reference

6 December 2017

1791-1798

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

6 December 2017

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Early commitment of adoptively transferred CD4+ T cells following particle-mediated DNA vaccination: implications for the study of immunomodulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Gene combination raises broad human immunodeficiency virus-specific cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

Imiquimod applied topically: a novel immune response modifier and new class of drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

inferred from DOI database lookup

7 January 2021

based on heuristic

Human immunodeficiency virus pseudotypes with expanded cellular and species tropism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.051

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.10.051

1 reference

6 December 2017

1 reference